Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
Gespeichert in:
| Veröffentlicht in: | The European respiratory journal 2016-11, Vol.48 (5), p.1517-1519 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1519 |
|---|---|
| container_issue | 5 |
| container_start_page | 1517 |
| container_title | The European respiratory journal |
| container_volume | 48 |
| creator | Riou, Marianne Seferian, Andrei Savale, Laurent Chaumais, Marie-Camille Guignabert, Christophe Canuet, Matthieu Magro, Pascal Rea, Delphine Sitbon, Olivier Jaïs, Xavier Humbert, Marc Montani, David |
| description | |
| doi_str_mv | 10.1183/13993003.01410-2016 |
| format | Article |
| fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1183_13993003_01410_2016</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>27799395</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-a118aaf16edc97583a729c586e4e3a9f633ec494efad132801f2fa66e944fe4e3</originalsourceid><addsrcrecordid>eNo9kM1OwzAQhC0EoqXwBEjIL5BiZ10nPqLyK1XiAufITdbUKIkj21HJ25O0lNNqZ2dWmo-QW86WnOdwz0EpYAyWjAvOkpRxeUbmk5pM8jmZM8Ug4QrkjFyF8M1GhwB-SWZplo1ZtZqT5hEjeuu8jta11Bna9XXjWu0Huhs69BHbMF10W9Guxt7rmqIx_UHc27ijWxf6aFu7pcbVtdvb9otWOuijVvfjGt2PLW0crsmF0XXAm7-5IJ_PTx_r12Tz_vK2ftgkJfAsJnrsp7XhEqtSZascdJaqcpVLFAhaGQmApVACja44pDnjJjVaSlRCmMmzIHD8W3oXgkdTdN42Y6eCs2KCV5zgFQd4xQRvTN0dU12_bbD6z5xowS8CHW3D</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Riou, Marianne ; Seferian, Andrei ; Savale, Laurent ; Chaumais, Marie-Camille ; Guignabert, Christophe ; Canuet, Matthieu ; Magro, Pascal ; Rea, Delphine ; Sitbon, Olivier ; Jaïs, Xavier ; Humbert, Marc ; Montani, David</creator><creatorcontrib>Riou, Marianne ; Seferian, Andrei ; Savale, Laurent ; Chaumais, Marie-Camille ; Guignabert, Christophe ; Canuet, Matthieu ; Magro, Pascal ; Rea, Delphine ; Sitbon, Olivier ; Jaïs, Xavier ; Humbert, Marc ; Montani, David</creatorcontrib><identifier>ISSN: 0903-1936</identifier><identifier>EISSN: 1399-3003</identifier><identifier>DOI: 10.1183/13993003.01410-2016</identifier><identifier>PMID: 27799395</identifier><language>eng</language><publisher>England</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Aniline Compounds - adverse effects ; Dasatinib - adverse effects ; Female ; Humans ; Hypertension, Pulmonary - chemically induced ; Lung - pathology ; Middle Aged ; Nitriles - adverse effects ; Pleural Effusion - chemically induced ; Protein Kinase Inhibitors - adverse effects ; Quinolines - adverse effects</subject><ispartof>The European respiratory journal, 2016-11, Vol.48 (5), p.1517-1519</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-a118aaf16edc97583a729c586e4e3a9f633ec494efad132801f2fa66e944fe4e3</citedby><cites>FETCH-LOGICAL-c317t-a118aaf16edc97583a729c586e4e3a9f633ec494efad132801f2fa66e944fe4e3</cites><orcidid>0000-0002-8545-4452</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27799395$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Riou, Marianne</creatorcontrib><creatorcontrib>Seferian, Andrei</creatorcontrib><creatorcontrib>Savale, Laurent</creatorcontrib><creatorcontrib>Chaumais, Marie-Camille</creatorcontrib><creatorcontrib>Guignabert, Christophe</creatorcontrib><creatorcontrib>Canuet, Matthieu</creatorcontrib><creatorcontrib>Magro, Pascal</creatorcontrib><creatorcontrib>Rea, Delphine</creatorcontrib><creatorcontrib>Sitbon, Olivier</creatorcontrib><creatorcontrib>Jaïs, Xavier</creatorcontrib><creatorcontrib>Humbert, Marc</creatorcontrib><creatorcontrib>Montani, David</creatorcontrib><title>Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity</title><title>The European respiratory journal</title><addtitle>Eur Respir J</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Aniline Compounds - adverse effects</subject><subject>Dasatinib - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Hypertension, Pulmonary - chemically induced</subject><subject>Lung - pathology</subject><subject>Middle Aged</subject><subject>Nitriles - adverse effects</subject><subject>Pleural Effusion - chemically induced</subject><subject>Protein Kinase Inhibitors - adverse effects</subject><subject>Quinolines - adverse effects</subject><issn>0903-1936</issn><issn>1399-3003</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kM1OwzAQhC0EoqXwBEjIL5BiZ10nPqLyK1XiAufITdbUKIkj21HJ25O0lNNqZ2dWmo-QW86WnOdwz0EpYAyWjAvOkpRxeUbmk5pM8jmZM8Ug4QrkjFyF8M1GhwB-SWZplo1ZtZqT5hEjeuu8jta11Bna9XXjWu0Huhs69BHbMF10W9Guxt7rmqIx_UHc27ijWxf6aFu7pcbVtdvb9otWOuijVvfjGt2PLW0crsmF0XXAm7-5IJ_PTx_r12Tz_vK2ftgkJfAsJnrsp7XhEqtSZascdJaqcpVLFAhaGQmApVACja44pDnjJjVaSlRCmMmzIHD8W3oXgkdTdN42Y6eCs2KCV5zgFQd4xQRvTN0dU12_bbD6z5xowS8CHW3D</recordid><startdate>201611</startdate><enddate>201611</enddate><creator>Riou, Marianne</creator><creator>Seferian, Andrei</creator><creator>Savale, Laurent</creator><creator>Chaumais, Marie-Camille</creator><creator>Guignabert, Christophe</creator><creator>Canuet, Matthieu</creator><creator>Magro, Pascal</creator><creator>Rea, Delphine</creator><creator>Sitbon, Olivier</creator><creator>Jaïs, Xavier</creator><creator>Humbert, Marc</creator><creator>Montani, David</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-8545-4452</orcidid></search><sort><creationdate>201611</creationdate><title>Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity</title><author>Riou, Marianne ; Seferian, Andrei ; Savale, Laurent ; Chaumais, Marie-Camille ; Guignabert, Christophe ; Canuet, Matthieu ; Magro, Pascal ; Rea, Delphine ; Sitbon, Olivier ; Jaïs, Xavier ; Humbert, Marc ; Montani, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-a118aaf16edc97583a729c586e4e3a9f633ec494efad132801f2fa66e944fe4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Aniline Compounds - adverse effects</topic><topic>Dasatinib - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Hypertension, Pulmonary - chemically induced</topic><topic>Lung - pathology</topic><topic>Middle Aged</topic><topic>Nitriles - adverse effects</topic><topic>Pleural Effusion - chemically induced</topic><topic>Protein Kinase Inhibitors - adverse effects</topic><topic>Quinolines - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riou, Marianne</creatorcontrib><creatorcontrib>Seferian, Andrei</creatorcontrib><creatorcontrib>Savale, Laurent</creatorcontrib><creatorcontrib>Chaumais, Marie-Camille</creatorcontrib><creatorcontrib>Guignabert, Christophe</creatorcontrib><creatorcontrib>Canuet, Matthieu</creatorcontrib><creatorcontrib>Magro, Pascal</creatorcontrib><creatorcontrib>Rea, Delphine</creatorcontrib><creatorcontrib>Sitbon, Olivier</creatorcontrib><creatorcontrib>Jaïs, Xavier</creatorcontrib><creatorcontrib>Humbert, Marc</creatorcontrib><creatorcontrib>Montani, David</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>The European respiratory journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riou, Marianne</au><au>Seferian, Andrei</au><au>Savale, Laurent</au><au>Chaumais, Marie-Camille</au><au>Guignabert, Christophe</au><au>Canuet, Matthieu</au><au>Magro, Pascal</au><au>Rea, Delphine</au><au>Sitbon, Olivier</au><au>Jaïs, Xavier</au><au>Humbert, Marc</au><au>Montani, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity</atitle><jtitle>The European respiratory journal</jtitle><addtitle>Eur Respir J</addtitle><date>2016-11</date><risdate>2016</risdate><volume>48</volume><issue>5</issue><spage>1517</spage><epage>1519</epage><pages>1517-1519</pages><issn>0903-1936</issn><eissn>1399-3003</eissn><cop>England</cop><pmid>27799395</pmid><doi>10.1183/13993003.01410-2016</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-8545-4452</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0903-1936 |
| ispartof | The European respiratory journal, 2016-11, Vol.48 (5), p.1517-1519 |
| issn | 0903-1936 1399-3003 |
| language | eng |
| recordid | cdi_crossref_primary_10_1183_13993003_01410_2016 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Aged Aged, 80 and over Aniline Compounds - adverse effects Dasatinib - adverse effects Female Humans Hypertension, Pulmonary - chemically induced Lung - pathology Middle Aged Nitriles - adverse effects Pleural Effusion - chemically induced Protein Kinase Inhibitors - adverse effects Quinolines - adverse effects |
| title | Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T16%3A59%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deterioration%20of%20pulmonary%20hypertension%20and%20pleural%20effusion%20with%20bosutinib%20following%20dasatinib%20lung%20toxicity&rft.jtitle=The%20European%20respiratory%20journal&rft.au=Riou,%20Marianne&rft.date=2016-11&rft.volume=48&rft.issue=5&rft.spage=1517&rft.epage=1519&rft.pages=1517-1519&rft.issn=0903-1936&rft.eissn=1399-3003&rft_id=info:doi/10.1183/13993003.01410-2016&rft_dat=%3Cpubmed_cross%3E27799395%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/27799395&rfr_iscdi=true |